Cargando...

Update in the medical therapy of Cushing’s disease

PURPOSE OF REVIEW: Recently developed agents treat Cushing’s disease by inhibiting adrenocorticotropic hormone (ACTH) secretion from corticotrope tumors or antagonizing cortisol action. RECENT FINDINGS: The dopamine agonist cabergoline and the somatostatin agonist pasireotide target ACTH secretion....

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Nieman, Lynnette K.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215263/
https://ncbi.nlm.nih.gov/pubmed/23807605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0b013e3283631809
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!